APA (7th ed.) Citation

Lee, S., Kim, Y., Cho, C. H., Kim, Y. T., Kim, S. M., Hur, S. Y., . . . Kang, S. B. (2018). An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021). Cancer research and treatment, 50(1), 195-203. https://doi.org/10.4143/crt.2016.376

Chicago Style (17th ed.) Citation

Lee, Shin-Wha, et al. "An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)." Cancer Research and Treatment 50, no. 1 (2018): 195-203. https://doi.org/10.4143/crt.2016.376.

MLA (9th ed.) Citation

Lee, Shin-Wha, et al. "An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)." Cancer Research and Treatment, vol. 50, no. 1, 2018, pp. 195-203, https://doi.org/10.4143/crt.2016.376.